DERMALIQ THERAPEUTICS
Dermaliq is developing the next generation of skin care therapies to enhance targeted penetration into skin tissues and to reduce unwanted side effects for millions of patients. The proprietary technology now owned by Dermaliq, called hyliQ™, is designed to allow cutaneous drug delivery with bioavailability. The technology enables the development of effective liquid drug products with exceptional cosmetic properties.
DERMALIQ THERAPEUTICS
Industry:
Fitness Health Care Pharmaceutical Wellness
Founded:
2022-01-01
Address:
Wilmington, Delaware, United States
Country:
United States
Website Url:
http://www.dermaliq.com
Status:
Active
Total Funding:
15 M USD
Similar Organizations
100Plus
100Plus is the fastest-growing Remote Patient Monitoring Platform for doctors to manage their chronic patients to avoid episodic care.
metaMe Health
MetaMe Health develops FDA-cleared prescription digital therapeutics for the treatment of gastrointestinal conditions.
NeuroFlow
NeuroFlow is a digital health company.
Circuit Living
Circuit Living is the nation's premier tech-enabled amenities provider designed specifically for residential and commercial communities.
Current Advisors List
Board_member
2022-01-01
Current Employees Featured
Frank Loscher CEO & President @ Dermaliq Therapeutics
CEO & President
Investors List
Beijing Whale Technology Corporation
Beijing Whale Technology Corporation investment in Series A - Dermaliq Therapeutics
3E Bioventures
3E Bioventures investment in Series A - Dermaliq Therapeutics
Official Site Inspections
http://www.dermaliq.com
- Host name: 217-160-0-203.elastic-ssl.ui-r.com
- IP address: 217.160.0.203
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Dermaliq Therapeutics"
Dermaliq Therapeutics - Crunchbase Company Profile …
Dermaliq's mission is to develop and sell the next generation of dermatology treatments for patients with severe unmet medical needs.See details»
Dermaliq Therapeutics, Inc. - LinkedIn
Dermaliq Therapeutics, Inc. | 373 followers on LinkedIn. Developing the next generation of skin care therapies | Dermaliq is developing the next generation of skin care therapies to enhance ...See details»
Imprint – dermaliq
Head Office: Dermaliq Therapeutics, Inc., 1201 North Market Street, Suite 111, Wilmington, DE 19801, USA CEO & President: Dr. Frank Löscher Registry No 6388009,See details»
Dermaliq Therapeutics - Funding, Financials, Valuation & Investors
Dermaliq's mission is to develop and sell the next generation of dermatology treatments for patients with severe unmet medical needs.See details»
Dermaliq Therapeutics 2025 Company Profile: …
Information on valuation, funding, cap tables, investors, and executives for Dermaliq Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Dermaliq Therapeutics Signs USD 15 Million Series A Round to …
Jan 18, 2022 Dermaliq Therapeutics, Inc. is an independent private pharmaceutical company emerged from Novaliq Spin-off to unlock value in the space of medical dermatology by using …See details»
Dermaliq Therapeutics - Contacts, Employees, Board Members, …
Dermaliq's mission is to develop and sell the next generation of dermatology treatments for patients with severe unmet medical needs.See details»
Dermaliq Therapeutics, Inc. (Dermaliq Therapeutics, Inc.) - 药物管 …
Dermaliq’s mission is to develop a new generation of superior topical drug therapies and medical skin care products with greater efficacy and fewer unwanted side effects for millions of …See details»
Dermaliq Therapeutics - VentureRadar
Dermaliq Therapeutics, Inc., is a private pharmaceutical company with a therapeutic focus on dermatology, founded in 2021 through a spin-off from Novaliq GmbH. Our mission is to …See details»
Frank Löscher - CEO, President & Co-Founder at Dermaliq ... - The …
Dr. Löscher is the CEO, President and co-founder of Dermaliq. Prior to joining Dermaliq, he was Chief Technology Officer of Novaliq GmbH, an ophthalmic drug development company.See details»
Dermaliq Therapeutics - Overview, News & Similar companies
View Dermaliq Therapeutics (www.dermaliq.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
Dermaliq Therapeutics - Biotech Careers
Dermaliq Therapeutics, Inc., is a newly formed Delaware-based specialty pharma company that emerged from Novaliq GmbH in Germany by spin off. It is leveraging its hyliQ® technology …See details»
Frank Löscher, Dr. rer. nat – CEO & President – Dermaliq ...
CEO & President at Dermaliq Therapeutics, Inc. · Frank Loescher holds the positions of Chief Executive Officer, President, and Co-Founder at Dermaliq Therapeutics Inc. He has a …See details»
Dermaliq Therapeutics Signs USD 15 Million Series A Round to …
Dermaliq Therapeutics Signs USD 15 Million Series A Round to Advance Three Transformative Drug Therapies into Clinical Trials Dermaliq Therapeutics, Inc. is an independent private …See details»
Dermaliq appoints Gordon Dow, PharmD, Michael Kuligowski, MD, …
Jul 14, 2022 New Scientific and Medical Advisory Board will play a strategic and pivotal role for Dermaliq in its mission to develop next generation dermatological products with unparalleled …See details»
DLQ-02 - Drug Targets, Indications, Patents - Synapse
Feb 15, 2025 DLQ-02: a CaN inhibitors Drug, Initially developed by Novaliq GmbH, Now, its global highest R&D status is Phase 2, Mechanism: CaN inhibitors (Calcineurin inhibitors), …See details»
Dermaliq Therapeutics announces positive topline results from …
Jul 16, 2024 Dermaliq was founded in 2021 as a spin-off from Novaliq GmbH, which developed the patent-protected revolutionary hyliQ ® technology, on the basis of which two successful …See details»
Dermaliq Therapeutics Announces Positive Topline Results from …
WILMINGTON, Delaware, July 16, 2024 / Biotech Newswire / -- Dermaliq Therapeutics, Inc. (Dermaliq), a private, clinical stage dermatology and medical aesthetics company, today …See details»
Dermaliq Strengthens Scientific & Medical Advisory Board with …
Feb 5, 2025 Wilmington (DE) USA, February 5, 2025 – Dermaliq Therapeutics, Inc. (Dermaliq) today announces that Ralf Paus, M.D., D.Sc., F.R.S.B. has joined the company’s Scientific …See details»